Skip to main content
Pharmena S.A. logo

Pharmena S.A. — Investor Relations & Filings

Ticker · PHR ISIN · PLPHRMN00011 LEI · 259400RHT936BBKW0955 WAR Manufacturing
Open in API
Filings indexed 649 across all filing types
Latest filing 2021-05-28 Interim / Quarterly Rep…
Country PL Poland
Listing WAR PHR

About Pharmena S.A.

https://www.pharmena.eu/

Pharmena S.A. is a specialty healthcare company focused on the development and commercialization of innovative products based on its patented active ingredient, 1-MNA. This molecule is a naturally occurring metabolite of niacin (vitamin B3) that plays a crucial role in cellular metabolism. The company's technology leverages the ability of 1-MNA to optimize the levels of the coenzyme NAD+, which decline with age and are vital for cellular function and regeneration. The product portfolio includes specialized cosmeceuticals, such as the Dermena line for hair loss, and dietary supplements designed to address the effects of cellular aging.

Recent filings

Filing Released Lang Actions
Pharmena Raport za I kwartał 2021
Interim / Quarterly Report Classification · 100% confidence The document is a table of contents for a 'Skonsolidowany Raport Kwartalny' (Consolidated Quarterly Report) for the period ending March 31, 2021. It contains detailed sections on financial statements (balance sheet, cash flow, income statement) and management commentary. Since it is a comprehensive financial report for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. Q1 2021
2021-05-28 Polish
PHARMENA Projekty uchwał na ZWZ w dniu 22 06 2021
AGM Information Classification · 98% confidence The document text is titled 'Projekty uchwał Zwyczajnego Walnego Zgromadzenia' (Draft resolutions of the Ordinary General Meeting) and details numerous resolutions passed during a meeting held on June 22, 2021. These resolutions cover the approval of annual reports (financial and management reports for 2020), coverage of net loss, and granting of 'absolutorium' (discharge/vote of confidence) to members of the Management Board and Supervisory Board. The core subject matter—resolutions concerning the approval of annual reports and discharge of management—is central to the proceedings of an Annual General Meeting (AGM). Since the document contains the resolutions themselves, it falls under the category of AGM Information.
2021-05-19 Polish
PHARMENA_Ogłoszenie o zwołaniu ZWZ w dniu 22 06 2021
AGM Information Classification · 99% confidence The document is titled "Ogłoszenie o zwołaniu Zwyczajnego Walnego Zgromadzenia Spółki..." which translates to "Announcement of the convening of the Ordinary General Meeting of the Company...". The text details the date (June 22, 2021), time, location, and a detailed agenda (Porządek obrad) covering the approval of financial statements for 2020, voting on management discharge (absolutorium), and election of the Supervisory Board members. It also outlines shareholder rights regarding registration, submitting agenda items, and proxy voting procedures. This content is characteristic of materials related to a General Meeting of Shareholders. The most specific category for this type of announcement is 'AGM Information' (AGM-R), as it is the official notice convening the meeting and detailing its proceedings.
2021-05-19 Polish
Zwołanie Zwyczajnego Walnego Zgromadzenia spółki Pharmena S.A. - Content (PL)
AGM Information Classification · 98% confidence The document text is in Polish and announces the convening of an 'Zwyczajnego Walnego Zgromadzenia' (Ordinary General Meeting) of PHARMENA S.A. on June 22, 2021. It explicitly states that the Management Board is enclosing the announcement for the convening of the AGM along with draft resolutions ('projektami uchwał'). This content directly relates to the preparation and announcement of a shareholder meeting, which aligns best with the 'AGM Information' category, as it is the official notice and associated materials for the meeting itself, rather than just a proxy solicitation (PSI) or a declaration of voting results (DVA). Given the context of announcing the meeting and attaching resolutions, AGM-R is the most appropriate classification.
2021-05-19 Polish
210415_JG_KNF_powiad_15.04.2012_zmiana
Director's Dealing Classification · 100% confidence The document is titled "Powiadomienie o transakcji/transakcjach*, o którym mowa w art. 19 ust. 1 rozporządzenia MAR" (Notification of a transaction/transactions referred to in Article 19(1) of the MAR Regulation). It details transactions (specifically 'Zbycie' - Disposal) conducted by a member of the management body ('Przewodniczący Rady Nadzorczej' - Chairman of the Supervisory Board) in the company's shares (Pharmena Spółka Akcyjna). This type of filing, reporting personal share transactions by directors and executives, directly corresponds to the definition of Director's Dealing (DIRS). The document is not a general regulatory filing (RNS) because it fits a much more specific category.
2021-04-16 Polish
Informacja o transakcjach wykonywanych przez osoby pełniące obowiązki zarządcze – korekta raportu 19/2021 - Content (PL)
Major Shareholding Notification Classification · 99% confidence The document text is in Polish and references Article 19(3) of Regulation (EU) No 596/2014 (MAR Regulation). It explicitly states that the Management Board received a change to a previous notification from Mr. Jerzy Gębicki, who is a member of the Supervisory Board (a person discharging managerial responsibilities). The content details a correction to a previous transaction notification concerning the sale of PHR shares, clarifying that a purchase transaction from 2020 was mistakenly included in the sale count. This type of filing, reporting personal share transactions by directors/executives (insider trades) under MAR, directly corresponds to the 'Director's Dealing' category. The document is a notification about a change/correction to an insider transaction report, which falls under DIRS (Director's Dealing). It is not a general announcement of a report publication (RPA) because it contains the substantive details of the correction itself, rather than just stating a report is attached or available.
2021-04-16 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.